Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development

· manilatimes.net

Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built

Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built

NEW...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI